Interleukine-6 and TNFα blockers provide only partial and short-term temporal improvement in cryopyrin-associated periodic syndrome

Ítems similars

• Differences in disease activity in cryopyrin-associated periodic syndrome in mutation-positive and mutation-negative patients
  per: Kostik, M, et al.
  Publicat: (2015)
• Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
  per: Mikhail M. Kostik
  Publicat: (2016-12-01)
• Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
  per: Mikhail M. Kostik
  Publicat: (2016-12-01)
• Anemia in children with JIA: is it really driven by hepcidin level, or by a set of factors of a chronic disease
  per: Egorov, Andrey, et al.
  Publicat: (2014)
• Interleukin-1β inhibitors for the treatment of cryopyrin-associated periodic syndrome
  per: Dhimolea, Eugen
  Publicat: (2011)